Clinical Trial Update: Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma [Phase 4]

View source ↗

Summary

Phase 4 pragmatic open-label randomized trial comparing Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) with usual ICS-LABA care for adults with u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ICS-LABA usual care (non-ellipta)
• Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: ACTIVE_NOT_RECRUITING